James R Mcnab - Net Worth and Insider Trading
James R Mcnab Net Worth
The estimated net worth of James R Mcnab is at least $3 Million dollars as of 2024-04-26. James R Mcnab is the Director of Curis Inc and owns about 185,938 shares of Curis Inc (CRIS) stock worth over $3 Million. James R Mcnab is also the Director of Titan Pharmaceuticals Inc and owns about 83 shares of Titan Pharmaceuticals Inc (TTNP) stock worth over $579. Details can be seen in James R Mcnab's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James R Mcnab has not made any transactions after 2018-09-21 and currently still holds the listed stock(s).
Transaction Summary of James R Mcnab
James R Mcnab Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James R Mcnab owns 3 companies in total, including Titan Pharmaceuticals Inc (TTNP) , Curis Inc (CRIS) , and Echo Therapeutics Inc (ECTE) .
Click here to see the complete history of James R Mcnab’s form 4 insider trades.
Insider Ownership Summary of James R Mcnab
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TTNP | Titan Pharmaceuticals Inc | 2021-02-10 | director |
| CRIS | Curis Inc | 2017-05-05 | director |
| ECTE | Echo Therapeutics Inc | 2003-10-09 | director |
James R Mcnab Latest Holdings Summary
James R Mcnab currently owns a total of 2 stocks. Among these stocks, James R Mcnab owns 185,938 shares of Curis Inc (CRIS) as of May 5, 2017, with a value of $3 Million and a weighting of 99.98%. James R Mcnab also owns 83 shares of Titan Pharmaceuticals Inc (TTNP) as of September 21, 2018, with a value of $579 and a weighting of 0.02%.
Latest Holdings of James R Mcnab
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRIS | Curis Inc | 2017-05-05 | 185,938 | 14.52 | 2,699,820 |
| TTNP | Titan Pharmaceuticals Inc | 2018-09-21 | 83 | 6.97 | 579 |
Holding Weightings of James R Mcnab
James R Mcnab Form 4 Trading Tracker
According to the SEC Form 4 filings, James R Mcnab has made a total of 0 transactions in Curis Inc (CRIS) over the past 5 years. The most-recent trade in Curis Inc is the sale of 15,255 shares on May 5, 2017, which brought James R Mcnab around $155,603.
According to the SEC Form 4 filings, James R Mcnab has made a total of 0 transactions in Titan Pharmaceuticals Inc (TTNP) over the past 5 years. The most-recent trade in Titan Pharmaceuticals Inc is the acquisition of 56 shares on September 21, 2018, which cost James R Mcnab around $50,000.
Insider Trading History of James R Mcnab
- 1
James R Mcnab Trading Performance
GuruFocus tracks the stock performance after each of James R Mcnab's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James R Mcnab is 3.02%. GuruFocus also compares James R Mcnab's trading performance to market benchmark return within the same time period. The performance of stocks bought by James R Mcnab within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James R Mcnab's insider trading performs compared to the benchmark.
Performance of James R Mcnab
Average Return
-28.89%
Outperforming Transactions
25%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.63 | 3.02 | 5.47 | -28.89 | -38.48 | -41.07 |
| Relative Return to S&P 500(%) | 19.33 | 9.43 | 8.65 | -39.78 | -46.96 | -49.05 |
James R Mcnab Ownership Network
Ownership Network List of James R Mcnab
Ownership Network Relation of James R Mcnab
James R Mcnab Owned Company Details
What does Titan Pharmaceuticals Inc do?
Who are the key executives at Titan Pharmaceuticals Inc?
James R Mcnab is the director of Titan Pharmaceuticals Inc. Other key executives at Titan Pharmaceuticals Inc include 10 percent owner Seow Gim Shen , 10 percent owner Sire Group Ltd. , and director & President and COO Katherine Beebe .
Titan Pharmaceuticals Inc (TTNP) Insider Trades Summary
Over the past 18 months, James R Mcnab made no insider transaction in Titan Pharmaceuticals Inc (TTNP). Other recent insider transactions involving Titan Pharmaceuticals Inc (TTNP) include a net sale of 7,438,436 shares made by David E. Lazar ,
In summary, during the past 3 months, insiders sold 0 shares of Titan Pharmaceuticals Inc (TTNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 374,797 shares of Titan Pharmaceuticals Inc (TTNP) were sold and 2,875 shares were bought by its insiders, resulting in a net sale of 371,922 shares.
Titan Pharmaceuticals Inc (TTNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Titan Pharmaceuticals Inc Insider Transactions
James R Mcnab Mailing Address
Above is the net worth, insider trading, and ownership report for James R Mcnab. You might contact James R Mcnab via mailing address: C/o Curis, Inc, 4 Maguire Road, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
